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Abstract
Background: Physical inactivity is associated with an increased risk of major chronic
diseases, although uncertainty exists about which chronic diseases, themselves, might
contribute to physical inactivity. The objective of this study was to compare the physical
activity of those with chronic diseases to healthy individuals using an objective measure
of physical activity.
Methods: We conducted a cross-sectional analysis of data from 96 706 participants aged
40 years or older from the UK Biobank prospective cohort study (2006–10). Diagnoses
were identified through ICD 9 and 10 coding within hospital admission records and a can-
cer registry linked to UK Biobank participants. We extracted summary physical activity
information from participants who wore a wrist-worn triaxial accelerometer for 7 days.
Statistical analyses included computation of adjusted geometric means and means using
general linear models.
Results: Participants with chronic disease undertook 9% or 61 minutes (95% confidence
interval: 57.8–64.8) less moderate activity and 11% or 3 minutes (95% confidence interval:
2.7–3.3) less vigorous activity per week than individuals without chronic disease.
Participants in every chronic-disease subgroup undertook less physical activity than
those without chronic disease. Sixty-seven diagnoses within these subgroups were asso-
ciated with lower moderate activity.
Conclusions: The cross-sectional association of physical activity with chronic disease is
broad. Given the substantial health benefits of being physically active, clinicians and
VC The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association. 1
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policymakers should be aware that their patients with any chronic disease are at greater
health risk from other diseases than anticipated because of their physical inactivity.
Key words: Physical activity, accelerometry, chronic disease
Introduction
Physical inactivity is globally recognized as an independent
risk factor for major chronic diseases.1 The Healthy People
2020 goals and the UK NICE guidelines specifically refer to
the importance of increasing physical activity (PA) as part of
the management of several chronic diseases such as cardiovas-
cular disease, diabetes and musculoskeletal disorders.2,3
However, the evidence base on which assumptions about in-
activity in specific disease subgroups are founded is limited
and what is available has been based on subjective question-
naire reports that suffer from substantial random and non-
random measurement error.4 The reference standard for mea-
suring free-living energy expenditure, and thus PA, is doubly
labelled water (DLW). However, DLW measurements are ex-
pensive and complex.5 Objective PA assessment with acceler-
ometers is a good low-cost alternative to DLW and captures
validated information on habitual levels of physical activity.6
We aimed to compare the PA of those with various chronic
diseases to healthy individuals using accelerometer data from
the UK Biobank study. The UK Biobank has collected the
world’s largest objective PA dataset to date using wrist-worn
accelerometers on a cohort of 103 720 participants with links
to various health records in the UK.7,8 This database, there-
fore, provides a unique opportunity to reliably compare any
potential difference in PA between participants with both
common and rarer chronic disease against their healthy peers.
Methods
Study design and participants
The UK Biobank data set includes data from 502 656 UK
adults between 40 and 69 years of age at recruitment
(2006–10) via a centrally coordinated invitation from
population-based National Health Service patient regis-
ters.8,9 Data were obtained by application to the UK
Biobank, reference number 15 856. UK Biobank obtained
ethical approval from the North West Multicentre
Research Ethics Committee, the National Information
Governance Board for Health and Social Care in England
and Wales, and the Community Health Index Advisory
Group in Scotland. All participants provided written in-
formed consent.
Exposures
Prevalence of chronic disease was identified using
International Classification of Diseases, Ninth and Tenth
Revisions (ICD 9 and 10) primary and secondary diagnoses
from hospital admission data in England, Scotland and
Wales and cancer registry data from 1997 up to accelerom-
eter wear time for each individual (2010–13). The ICD
codes were organized into 12 chronic-disease subgroups by
ICD Chapters. These included neoplasms; infectious and
parasitic diseases; diseases of the circulatory system; men-
tal and behavioural disorders; diseases of the eye and ad-
nexa; diseases of the ear and mastoid process; diseases of
the blood and blood-forming organs and certain disorders
involving the immune mechanism; diseases of the digestive
system; diseases of the genitourinary system; diseases of
the musculoskeletal system and connective tissue, endo-
crine, nutritional and metabolic diseases; diseases of the
nervous system; and diseases of the respiratory system.10,11
Specific ICD codes were taken from these chapters in com-
bination to identify specific disorders; see Supplementary
materials section ICD codes, available as Supplementary
Key Messages
• Almost all patients with a chronic disease undertook less physical activity than healthy individuals.
• Participants with any chronic disease engaged in 6% less moderate and 11% less vigorous activity/week (geometric
mean for chronic disease vs without) than individuals without chronic disease.
• Individuals with mental health disorders had the lowest moderate activity (559 minutes/week) compared with individu-
als without chronic disease (705.1 minutes/week).
• Individuals with cardiovascular diseases had the lowest vigorous activity (23.1 minutes/week) compared with individu-
als without chronic disease (27.0 minutes/week).
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data at IJE online. We did not select patients on the basis
that they have one and only one disease out of all possible
diseases. To enable us to capture the main associations of
PA with a particular chronic disease, a person was defined
as having a specific disease if they suffered from that dis-
ease and that disease only within the chronic-disease sub-
group. Those who suffered from more than one chronic
disease within the subgroup were excluded from the com-
parison for that disease.
Outcomes
PA was measured using Axivity AX3 wrist-worn triaxial
accelerometers, collected from May 2013 until December
2015. Each individual had PA measured from their domi-
nant wrist over a 7-day period at 100 Hz with a dynamic
range of 68 g with cut points set to 5-second epochs.
Details on data processing can be found elsewhere.7
From the processed data, minutes of moderate and vigorous
PA were calculated by considering the percentage of time spent
above 100-milligravities (mg) activity intensity for moderate PA
and above 400-mg intensity for vigorous PA.12 As both moder-
ate and vigorous PA are derived from activity intensity and are
more intuitive to comprehend, mean acceleration is not de-
scribed in detail in this paper but can be found in
Supplementary Table 1.
Of the 103 720 participants who provided accelerome-
try data, 7001 participants were excluded due to poor ac-
celerometer wear time—defined as not having at least
3 days (72 hours) of data and or lacking data in each 1-
hour period of the 24-hour cycle scattered over multiple
days. A further 11 were excluded due to poor device cali-
bration where recalibration by the preceding or subsequent
measurement was not possible due to insufficient data and
2 were excluded due to discordant dates of device wear,
leaving a total of 96 706 participants.
Table 1. Sample characteristics by presence or absence of chronic diseases and sex
Characteristic No chronic disease Chronic disease
Women (n¼31 901) Men (n¼23 493) Women (n¼22 547) Men (n¼18 765)
Age (years)a 60.7 (7.7) 61.0 (8.0) 63.5 (7.5) 65.5 (7.1)
Weight (kg)a 69.0 (12.7) 84.4 (13.3) 71.7 (14.0) 85.7 (14.0)
Height (cm)a 163.6 (6.2) 176.8 (6.6) 163.1 (6.2) 176.0 (6.7)
BMI (kg/m2)a 25.8 (4.6) 27.0 (3.9) 26.9 (5.1) 27.7 (4.1)
Smoking status (%)
Never 19 980 (62.6) 13 178 (56.1) 13 139 (58.3) 8781 (46.8)
Previous 9987 (31.3) 8364 (35.6) 7998 (35.5) 8336 (44.4)
Current 1864 (5.8) 1895 (8.1) 1342 (6.0) 1584 (8.4)
Alcohol intake (%)
Daily or almost daily 6326 (19.8) 6500 (27.7) 3922 (17.4) 5337 (28.4)
Three or four times a week 8127 (25.5) 6982 (29.7) 4882 (21.7) 5128 (27.3)
Once or twice a week 8206 (25.7) 5859 (24.9) 5651 (25.1) 4530 (24.1)
One to three times a month 3916 (12.3) 1980 (8.4) 3053 (13.5) 1559 (8.3)
Special occasions only 3525 (11.1) 1235 (5.3) 3213 (14.3) 1208 (6.4)
Never 1779 (5.6) 920 (3.9) 1799 (8.0) 988 (5.3)
Highest qualification (%)
None 1996 (6.3) 1480 (6.3) 2316 (10.3) 2211 (11.78)
GCSE or equivalent 5265 (16.5) 2516 (10.7) 4079 (18.1) 2329 (12.41)
A-level or equivalent 2285 (7.2) 1383 (5.9) 1340 (5.9) 950 (5.06)
Degree or equivalent 22 059 (69.2) 17 891 (76.2) 14 569 (64.6) 13 065 (69.62)
Ethnicity (%)
White 30 729 (96.4) 22 672 (96.6) 21 811 (96.8) 18 173 (96.9)
Non-White 1162 (3.6) 808 (3.4) 724 (3.2) 583 (3.1)
Accelerometer wear time (hours/day)a 22.8 (2.3) 22.8 (2.3) 22.8 (2.2) 22.9 (2.22)
Accelerometer wear days/weeka 6.6 (0.7) 6.7 (0.7) 6.7 (0.6) 6.7 (0.6)
Mean acceleration (mg/24 hours)b 28.4 (28.2–28.6) 27.5 (27.2–27.8) 26.3 (26.1–26.6) 25.1 (24.8–25.4)
Moderate activity (minutes/week)b 735.2 (726.6–743.9) 682.2 (672.5–692.0) 650.8 (640.3–661.4) 594.6 (583.6–605.9)
Vigorous activity (minutes/week)b 25.3 (24.7–25.9) 30.2 (29.3–31.1) 20.9 (20.3–21.5) 24.4 (23.6–25.2)
aMean (standard deviation).
bGeometric mean adjusted for age and body mass index (95% confidence interval).
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Statistical analyses
Descriptive statistics are presented for anthropometric and
lifestyle characteristics subdivided by chronic-disease sta-
tus overall and sex in Table 1. Additionally, geometric
means [95% confidence intervals (CIs)] for activity inten-
sity and minutes of moderate and vigorous PA adjusted for
age and body mass index (BMI) are presented, subdivided
by chronic-disease status and sex.
Adjusted geometric means (95% CI) for average accelera-
tion and minutes of moderate and vigorous PA are presented
for participants with a previously diagnosed chronic condi-
tion and those participants with no prior history of chronic
disease adjusted for sex, age, BMI, smoking status, alcohol
consumption, region, area deprivation using the Townsend
deprivation index13 and ethnicity. Statistical comparison of
means between disease-specific subgroups and those with no
history of that disease were made using general linear mod-
els; e.g. mean minutes of moderate PA among participants
with a previous diagnosis of any cancer were compared with
participants with no previous history of a cancer diagnosis
(Table 2). We conducted sensitivity analyses to determine the
effect of 625 mg change in PA on either side of activity cut-
offs in individuals without chronic disease compared with
individuals with cardiovascular disease.
Where statistical testing was used for comparison of the
samples with an individual chronic disease to those with-
out, we used a p-value of <0.001 to take into account the
problem of multiple comparisons.
Results
The analytic sample consisted of 96 706 participants aged
between 43 and 79 years at the time they wore accelerome-
ters. Overall, 44% of participants had one or more chronic
diseases (Table 1). For within-disease category analyses,
the following numbers were excluded due to the presence
of two or more conditions within the category: 1 for infec-
tious diseases; 593 for malignant cancer; 2728 for cardio-
vascular disease; 265 for endocrine and metabolic
disorders; 70 for chronic neurologic disorders; 59 for men-
tal health disorders; 15 for chronic haematological disor-
ders; 375 for chronic respiratory disorders; 3396 for
chronic gastrointestinal diseases; 684 for chronic genitouri-
nary disorders; 14 for chronic ear, mastoid and hearing
disorders; 603 for chronic eye disorders; and 697 for
chronic musculoskeletal disorders. Compared with partici-
pants without chronic disease, both men and women with
chronic disease were on average older, more likely to be
ex-smokers, less educated and were less active, with lower
activity intensity over 24 hours, lower moderate PA and
vigorous PA levels per week. Compared with non-diseased
individuals, those with chronic disease had lower alcohol
intake.
Figure 1 presents moderate PA data for participants
with and without chronic disease. Participants without
chronic disease were found to undertake 61 minutes (9%)
more moderate PA (95% CI: 57.6–65.0) per week than
individuals with chronic disease, on average. Those with
Figure 1. Geometric mean moderate activity in minutes per week for participants with and without chronic diseases.
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Figure 2. Geometric mean moderate activity in minutes per week for participants without chronic diseases and various chronic-disease subgroups.
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no chronic disease averaged 705 minutes per week of mod-
erate PA whereas estimates for all chronic-disease sub-
groups were lower. The greatest difference in moderate PA
was seen in individuals with mental health disorders whose
mean was 559 minutes/week, followed by cardiovascular
diseases at 589 minutes/week and chronic neurological dis-
orders at 604 minutes/week. Furthermore, participants
without chronic disease engaged in 3 minutes (11%) more
vigorous PA (95% CI: 2.7–3.3) per week than individuals
with chronic disease, on average (Supplementary Table 1,
available as Supplementary data at IJE online). The great-
est difference for vigorous PA was found in individuals
with cardiovascular diseases with a mean of 23.1 minutes/
week followed by chronic infectious diseases at
23.8 minutes/week and chronic neurological disorders at
23.9 minutes/week.
The chronic-disease subgroups were populated by 147
individual disease diagnoses. Figure 2 provides moderate
PA estimates and CIs for each. Almost half (67) were asso-
ciated with a lower level of moderate PA when compared
with individuals without chronic disease. Had we used the
corrected Bonferroni p-value of <0.00034, we would have
found only 55 of the individual disease diagnoses to be as-
sociated with moderate PA. For almost all chronic diseases,
the point estimate of the mean moderate PA per week was
lower than that for healthy individuals. The specific dis-
eases with clearly lower weekly moderate PA include indi-
viduals with: systemic atrophies primarily affecting the
central nervous system (70% lower), multiple sclerosis
(44% lower), heart failure (44% lower), arterial thrombo-
embolism (39.6% lower), COPD (35% lower), primary dis-
orders of muscles (32% lower), oesophageal cancer (32%
lower), bronchus and lung cancer (30% lower), chronic re-
nal failure (30% lower) and aneurysms (30% lower).
Only 11 of the comparisons of vigorous-activity levels
between chronic-disease subgroups and non-diseased had
CIs that excluded a mean difference of zero, but a deficit in
PA for diseased when compared with non-diseased was ev-
ident across diseases (Supplementary Table 1, available as
Supplementary data at IJE online).
Current smokers without chronic disease were less
moderately active than non-smokers without chronic dis-
ease (current smoker 643 minutes, previous 732 minutes,
never 710 minutes) and also less vigorously active (current
23 minutes, previous 28 minutes, never 27 minutes) (data
not shown). An inverse relationship was found between
moderate PA and both age and BMI when narrower cate-
gories were used for stratification (Supplementary Figures
1 and 2, available as Supplementary data at IJE online).
The sensitivity analyses for 625-mg change in moderate
(100 mg) and vigorous (400 mg) cut-offs for acceleration
changed the absolute minutes per week of activity, but the
differences in PA between healthy participants and disease
subgroups remained (Supplementary Table 2, available as
Supplementary data at IJE online).
Discussion
In this large prospective cohort study, we find clear evi-
dence of lower PA levels among individuals with a prior di-
agnosis of chronic disease as compared with healthy
individuals.
The greatest difference for moderate PA was seen for
those with mental health disorders who averaged 2.4 hours
less per week of moderate PA. This was followed by car-
diovascular, neurological, endocrine and metabolic disor-
ders, respiratory disorders, eye disorders and malignant
cancer with lower levels of moderate PA between 1 and
2 hours per week. Of the 147 chronic diseases examined,
accelerometry readings were lower for almost every
chronic disease, with 67 being associated with lower mod-
erate PA. This is despite the fact that the number of partici-
pants in each specific disease category was low for many
and power-limited.
In a cross-sectional analysis of this kind, lower PA levels
associated with disease might be explained by different
mechanisms. The most readily anticipated is that the dis-
ease might be directly responsible for lower activity levels
due to a reduced exercise capacity. This could be induced,
e.g. by either reduced cardiopulmonary function or muscu-
loskeletal dysfunction.14 However, not all of the diseases
examined should have this effect; e.g. one might not expect
gastrointestinal or genitourinary disorders to limit activity.
As such, it is perhaps surprising that PA-measured objec-
tively is lower across virtually all chronic diseases investi-
gated. Some of the associations in these unexpected disease
fields might be explained by the fact that physical inactiv-
ity leads to increased risk of these conditions and the indi-
viduals may have been habitually less active than their
healthy counterparts for some time in order to develop the
conditions. It would be surprising, however, if this, to-
gether with the disease effects described previously,
accounted for the low PA found for all chronic diseases.
Possibly, just the fact of having a disease influences peo-
ple to be less active, either through adoption of the sick
role or concomitant undiagnosed depression. Regardless,
the individuals so affected are deprived of the beneficial
effects that PA might provide.15 An awareness of this and
consequent implementations of a means to address it
should be on the agenda of all clinicians and policymakers
with a responsibility for patients with any chronic disease.
The mean moderate PA of 705 minutes per week for
healthy individuals appears high in comparison to previous
estimates based on self-report measures and the WHO
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guideline of 150 minutes minimum of leisure activity.16
However, this should not be surprising. Accelerometry
captures habitual activity that might not necessarily be
recalled and included in self-report and therefore might be
expected to provide higher results. Matthews et al. recently
reported that participants in the USA-based National
Health and Nutrition Examination Survey (NHANES)
study were estimated to take 1.7 hours of moderate to vig-
orous activity per day based on accelerometry measure-
ment.17 This is not very different to the 1.67 hours per day
we estimated here for the UK Biobank participants who
were free of chronic disease.
Limitations
The key comparison made here is between those for whom
no evidence exists for a diagnosis of a chronic disease and
those who are identified as having such a condition within
hospital records. The accuracy of the conclusions drawn is
therefore limited by the accuracy of coding within these
data, which has been discussed elsewhere,15 as with all ob-
servational studies.
We have tried to control for the confounding effect of
multi-morbidity by defining specific diagnoses as being
present in the individual in the absence of other chronic di-
agnoses within that chronic-disease subgroup. The exclu-
sion of diagnoses outside each chronic-disease subgroup
for this purpose reduced sample sizes and limited examina-
tion of the research question for some diseases. The inclu-
sion of those with only one disease also removed the
possibility of examining the effects of multi-morbidity.
Future work could address the implications of multi-
morbidity on PA.
The response rate to invitations to become a participant
in UK Biobank might affect the generalizability of the prev-
alence estimates we found.18 However, for this to produce
the differences seen here between participants with and
without chronic disease, there would have to have been a
different association between having a disease and being
active among respondents compared with non-
respondents. This is possible but it seems much more likely
that the inactive among those with chronic disease would
have been the non-responders, the effect of which would
be to bias the results towards the null.
The thresholds chosen for the Actigraph GT3x acceler-
ometer for moderate and vigorous PA intensities at
around 100 mg for three metabolic equivalents (moderate
PA) and 400 mg for six metabolic equivalents (vigorous
PA) were based on a small study of 30 Norwegian
adults.5 Whilst this validation study was small, the
authors conducted sensitivity analyses showing no appre-
ciable change in the CIs if these thresholds were varied
but did show modest variation in result magnitude. We
also conducted sensitivity analysis on our data using dif-
ferent thresholds and found the main associations
reported here remained.
Conclusion
We found evidence of an association of physical inactivity
with chronic disease that is broad. Clinicians and policy-
makers should be aware of the extent to which lower PA is
associated with chronic disease and pay more attention to
estimating PA in those with chronic disease, providing ad-
vice and programmes to address the problem. It is impor-
tant to ensure that this subset of the population also
accrues the health benefits obtained from adequate PA.
Supplementary data
Supplementary data are available at IJE online.
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